100 mM Sodium salt solution
Cytidine 5'-triphosphate, Sodium salt
Cat. No. | Amount | Price (EUR) | Buy / Note |
---|---|---|---|
NU-1011 | 1 ml (100 mM) | 49,90 | Add to Basket/Quote Add to Notepad |
NU-1011-100ML | 100 ml (100 mM) | Ask for Quotation |
For general laboratory use.
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
Shelf Life: 12 months
Molecular Formula: C9H16N3O14P3 (free acid)
Molecular Weight: 483.16 g/mol (free acid)
CAS#: 36051-68-0
EC number: 252-849-3
Purity: ≥ 99 % (HPLC)
Form: clear aqueous solution
Concentration: 100 mM ±2 %
pH: 8.0 ±0.2 (22 °C)
Spectroscopic Properties: λmax 271 nm, ε 8.9 L mmol-1 cm-1 (Tris-HCl pH 7.0)
Applications:
Physiological role in coronary artery disease[1]
Physiolocal role in lipid metabolism[2]
Physiological role in farnesol induced apoptosis[3]
Description:
Ultrapure CTP supplied as clear aqueous solution.
Specific Ligands:
CTP synthase[4]
Phosphocholine cytidyltransferase alpha[2]
Ligand for purinergic receptors:
P2Y6[5]
P2X3[6]
BIOZ Product Citations:
Selected References:
[1] Lui et al. (2010) Evaluation of CT perfusion in setting of cerebral ischemia:patterns and pitfalls. American Journal of Neuroradiology 31:1552.
[2] Luoma (2010) Gene activation regresses artheriosclerosis, promotes health, and enhances longevity. Lipids in health and disease 9:67.
[3] Joo et al. (2010) Molecular mechanisms involved in farnesol-induced apotosis. Cancer letters 287:123.
[4] Cabeen et al. (2010) A metabolic assembly line in bacteria. Nature Cell Biology 12:731.
[5]Jayasekara et al. (2013) 4-Alkoxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor. MedChemComm. 4 (8):1156.
[6]Garzia-Guzman et al. (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoreceptor. Mol. Brain Res. 47 (1):59.
Spangler et al. (2011) Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2', (3')-substituted purine and pyrimidine nucleotides. J. Pharmacol. Exp. Ther. 336 (1):234.